The University of Arizona
Institutional Knowledge Map (KMap)
Picture of Fei Yin

Fei Yin

Associate Professor, Pharmacology | Associate Professor, Neuroscience - GIDP | Assistant Director, Translational Neuroscience | Assistant Research Scientist | Member of the Graduate Faculty | Associate Professor, Clinical Translational Sciences

Pharmacology
Map Page
40+ Collaborators
$17.6M / $34.9M Funding
20+ Grants
60+ Publications
4+ Tech/Patents

Research Area

alzheimer's disease, aging, metabolism, neurodegeneration, brain, brain aging, neuroscience, alzheimer's, sex differences, bioenergetics, brain health, mitochondrial function, perimenopause, lipid metabolism, mitochondria, synaptic plasticity, female brain, genetics, menopause, nutrition, inflammation, gut microbiota, consortium, arizona, match, neurodegenerative diseases

    Page 1 of 5

    Chart
    Bar chart with 15 bars.
    The chart has 1 X axis displaying Year.
    The chart has 1 Y axis displaying values. Data ranges from 1 to 10.
    End of interactive chart.
    Recent

    Career pathways, part 15

    2024
    career development, professional growth, employment trends

    Heparan sulfate modified proteins affect cellular processes central to neurodegeneration and modulate presenilin function

    2024
    neurodegeneration, cellular processes, protein modification

    Altering heparan sulfate suppresses cell abnormalities and neuron loss in i>Drosophila presenilin<i> model of Alzheimer Disease.

    2024
    alzheimer's disease, neurodegeneration, heparan sulfate, drosophila model

    Sex‐ and APOE‐Specific Transcriptomic Signatures in Alzheimer’s Disease: An AZ‐ADRC‐Research Education Scholars Team Science Project

    2023

    Loss of fatty acid degradation by astrocytic mitochondria triggers neuroinflammation and neurodegeneration

    2023
    neuroinflammation, neurodegeneration, fatty acid degradation, astrocytic mitochondria, loss

    Lipid metabolism and Alzheimer's disease: clinical evidence, mechanistic link and therapeutic promise

    2022
    alzheimer's disease, lipid metabolism, clinical evidence, mechanistic link, therapeutic promise

    A tale of two systems: Lessons learned from female mid-life aging with implications for Alzheimer’s prevention treatment

    2022
    aging, alzheimer's, female health, mid-life, treatment

    Transcriptional Coordination between Mitochondrial and Nuclear Genomes for Oxidative Phosphorylation Is Disrupted in Alzheimer’s Brain

    2022

    Methionine restriction alleviates age-associated cognitive decline via fibroblast growth factor 21

    2021
    aging, cognitive decline, nutrition, metabolism, growth factors

    Mitochondria-Targeted Therapeutics for Alzheimer s Disease: The Good, the Bad, the Potential.

    2021
    alzheimer's disease, mitochondria, therapeutics, research, neurodegeneration

    • Shenfeng Qiu

    • Andrew Rouse

    • Fayez Ghishan

    • Wei Wang

    • Theodore Trouard

    Page 1 of 9

    • Molecular Targets of Pharmacological Agents

    • Neuropharmacolgy

    • Neurodegenerative Diseases: Pathomechanism and Therapeutic Approaches

    Fei Yin | KMap Profile - Institutional Knowledge Map (KMap)